Literature DB >> 10642593

Defective HDL particle uptake in ob/ob hepatocytes causes decreased recycling, degradation, and selective lipid uptake.

D L Silver1, N Wang, A R Tall.   

Abstract

Levels of plasma HDL are determined in part by catabolism in the liver. However, it is unclear how the hepatic catabolism of holo-HDL is regulated or mediated. Recently, we found that ob/ob mice have defective liver catabolism of HDL apoproteins in vivo that can be reversed by low-dose leptin treatment. Here we examined HDL catabolism and trafficking at the cellular level using isolated hepatocytes. We demonstrate that ob/ob hepatocytes have reduced binding, association, degradation, and resecretion of HDL apoproteins and 50% less selective lipid uptake relative to wild-type hepatocytes. In addition, HDL apoproteins were found to colocalize with transferrin in the general endosomal recycling compartment (ERC) in wild-type hepatocytes. However, the localization to the ERC was markedly reduced in ob/ob hepatocytes. Filipin staining of cellular cholesterol revealed decreased cholesterol in the ERC in ob/ob hepatocytes. Defects in HDL cell association and cholesterol distribution were reversed by leptin administration. The findings show a major defect in HDL uptake and recycling in ob/ob hepatocytes and suggest that HDL recycling through the ERC plays a role in the determination of plasma HDL protein and cholesterol levels.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10642593      PMCID: PMC377432          DOI: 10.1172/JCI8087

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  28 in total

1.  Increased high density lipoprotein (HDL), defective hepatic catabolism of ApoA-I and ApoA-II, and decreased ApoA-I mRNA in ob/ob mice. Possible role of leptin in stimulation of HDL turnover.

Authors:  D L Silver; X C Jiang; A R Tall
Journal:  J Biol Chem       Date:  1999-02-12       Impact factor: 5.157

2.  The multicatalytic proteinase. Multiple proteolytic activities.

Authors:  A J Rivett
Journal:  J Biol Chem       Date:  1989-07-25       Impact factor: 5.157

3.  ApoA-II maintains HDL levels in part by inhibition of hepatic lipase. Studies In apoA-II and hepatic lipase double knockout mice.

Authors:  W Weng; N A Brandenburg; S Zhong; J Halkias; L Wu; X C Jiang; A Tall; J L Breslow
Journal:  J Lipid Res       Date:  1999-06       Impact factor: 5.922

4.  Extraction of cholesterol with methyl-beta-cyclodextrin perturbs formation of clathrin-coated endocytic vesicles.

Authors:  S K Rodal; G Skretting; O Garred; F Vilhardt; B van Deurs; K Sandvig
Journal:  Mol Biol Cell       Date:  1999-04       Impact factor: 4.138

5.  Degradation of macrophage ApoE in a nonlysosomal compartment. Regulation by sterols.

Authors:  H Duan; C Y Lin; T Mazzone
Journal:  J Biol Chem       Date:  1997-12-05       Impact factor: 5.157

6.  Receptor-mediated internalization of high density lipoprotein by rat sinusoidal liver cells: identification of a nonlysosomal endocytic pathway by fluorescence-labeled ligand.

Authors:  K Takata; S Horiuchi; A T Rahim; Y Morino
Journal:  J Lipid Res       Date:  1988-09       Impact factor: 5.922

7.  Targeted mutation reveals a central role for SR-BI in hepatic selective uptake of high density lipoprotein cholesterol.

Authors:  M L Varban; F Rinninger; N Wang; V Fairchild-Huntress; J H Dunmore; Q Fang; M L Gosselin; K L Dixon; J D Deeds; S L Acton; A R Tall; D Huszar
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-14       Impact factor: 11.205

8.  Cholesterol-dependent retention of GPI-anchored proteins in endosomes.

Authors:  S Mayor; S Sabharanjak; F R Maxfield
Journal:  EMBO J       Date:  1998-08-17       Impact factor: 11.598

9.  De novo cholesterol synthesis in three different animal models of diabetes.

Authors:  K R Feingold; S R Lear; A H Moser
Journal:  Diabetologia       Date:  1984-03       Impact factor: 10.122

10.  Cholesterol distribution in living cells: fluorescence imaging using dehydroergosterol as a fluorescent cholesterol analog.

Authors:  S Mukherjee; X Zha; I Tabas; F R Maxfield
Journal:  Biophys J       Date:  1998-10       Impact factor: 4.033

View more
  27 in total

1.  Scavenger receptor CD36 mediates uptake of high density lipoproteins in mice and by cultured cells.

Authors:  May Brundert; Joerg Heeren; Martin Merkel; Antonella Carambia; Johannes Herkel; Peter Groitl; Thomas Dobner; Rajasekhar Ramakrishnan; Kathryn J Moore; Franz Rinninger
Journal:  J Lipid Res       Date:  2011-01-09       Impact factor: 5.922

Review 2.  Metabolism of high density lipoproteins in liver cancer.

Authors:  Jing-Ting Jiang; Ning Xu; Chang-Ping Wu
Journal:  World J Gastroenterol       Date:  2007-06-21       Impact factor: 5.742

3.  Dietary cholesterol and apolipoprotein A-I are trafficked in endosomes and lysosomes in the live zebrafish intestine.

Authors:  Jessica P Otis; Meng-Chieh Shen; Blake A Caldwell; Oscar E Reyes Gaido; Steven A Farber
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2019-01-10       Impact factor: 4.052

4.  FoxO transcription factors are required for hepatic HDL cholesterol clearance.

Authors:  Samuel X Lee; Markus Heine; Christian Schlein; Rajasekhar Ramakrishnan; Jing Liu; Gabriella Belnavis; Ido Haimi; Alexander W Fischer; Henry N Ginsberg; Joerg Heeren; Franz Rinninger; Rebecca A Haeusler
Journal:  J Clin Invest       Date:  2018-03-19       Impact factor: 14.808

5.  High density lipoprotein metabolism in low density lipoprotein receptor-deficient mice.

Authors:  Franz Rinninger; Markus Heine; Roshni Singaraja; Michael Hayden; May Brundert; Rajasekhar Ramakrishnan; Joerg Heeren
Journal:  J Lipid Res       Date:  2014-06-22       Impact factor: 5.922

6.  HDL from apoA1 transgenic mice expressing the 4WF isoform is resistant to oxidative loss of function.

Authors:  Stela Z Berisha; Greg Brubaker; Takhar Kasumov; Kimberly T Hung; Patricia M DiBello; Ying Huang; Ling Li; Belinda Willard; Katherine A Pollard; Laura E Nagy; Stanley L Hazen; Jonathan D Smith
Journal:  J Lipid Res       Date:  2015-01-05       Impact factor: 5.922

7.  Evidence that leptin contributes to intestinal cholesterol absorption in obese (ob/ob) mice and wild-type mice.

Authors:  M Igel; B Lindenthal; U Giesa; Bergmann K von
Journal:  Lipids       Date:  2002-02       Impact factor: 1.880

8.  Transgenic expression of cholesterol 7alpha-hydroxylase in the liver prevents high-fat diet-induced obesity and insulin resistance in mice.

Authors:  Tiangang Li; Erika Owsley; Michelle Matozel; Peter Hsu; Colleen M Novak; John Y L Chiang
Journal:  Hepatology       Date:  2010-08       Impact factor: 17.425

9.  Melanocortin signaling in the CNS directly regulates circulating cholesterol.

Authors:  Diego Perez-Tilve; Susanna M Hofmann; Joshua Basford; Ruben Nogueiras; Paul T Pfluger; James T Patterson; Erin Grant; Hilary E Wilson-Perez; Norman A Granholm; Myrtha Arnold; James L Trevaskis; Andrew A Butler; William S Davidson; Stephen C Woods; Stephen C Benoit; Mark W Sleeman; Richard D DiMarchi; David Y Hui; Matthias H Tschöp
Journal:  Nat Neurosci       Date:  2010-06-06       Impact factor: 24.884

10.  Obesity-associated improvements in metabolic profile through expansion of adipose tissue.

Authors:  Ja-Young Kim; Esther van de Wall; Mathieu Laplante; Anthony Azzara; Maria E Trujillo; Susanna M Hofmann; Todd Schraw; Jorge L Durand; Hua Li; Guangyu Li; Linda A Jelicks; Mark F Mehler; David Y Hui; Yves Deshaies; Gerald I Shulman; Gary J Schwartz; Philipp E Scherer
Journal:  J Clin Invest       Date:  2007-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.